ScienceDex / Researcher record
Mirsalis, Jon
- SRI International (no department on record)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
- Sustained Excellence
- Top 5% Funded
- Long-Funded
NIH Funding · FY2021
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2007 | $12,194,454 | 2 | #124 |
| 2011 | $792,692 | 1 | #9,099 |
| 2014 | $516,830 | 1 | #14,902 |
| 2015 | $537,730 | 1 | #14,598 |
| 2016 | $4,756,824 | 8 | #640 |
| 2017 | $11,924,298 | 13 | #104 |
| 2018 | $3,061,863 | 4 | #1,360 |
| 2019 | $3,090,728 | 4 | #1,494 |
| 2021 | $6,787,366 | 14 | #452 |
| 2022 | $3,028,790 | 6 | #1,708 |
| 2023 | $7,572,154 | 4 | #397 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20072 records
- FY20111 record
- FY20141 record
- FY20151 record
- FY20168 records
- FY201713 records
- FY20184 records
- FY20194 records
- FY2021 · selected14 records
- FY20226 records
- FY20234 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award records by amount
NIH award records listing Mirsalis, Jon as a PI. Multi-PI records show the full award amount for context.
- 272201800001I-P00002-759302000005-5N01Contact PITask D06: Nonclinical Microbiological, Safety, Toxicology, and Pharmacokinetic Services$2.6Maward amount
- 272201800001I-0-759302100007-1N01Contact PITask D07: GLP 28-day repeat toxicology and cardiovascular telemetry assessment of Lassa antiviral in cynomolgus macaques$1.8Maward amount
- 272201800001I-P00002-759302000005-1N01Contact PITask D06: Nonclinical Microbiological, Safety, Toxicology, and Pharmacokinetic Services$438.5Kaward amount
- 272201800001I-0-759302100006-1N01Contact PITask C13: GMP manufacturing of Oxfendazole clinical trial material and stability study$381Kaward amount
- 272201400006I-P00001-759302000001-1N01Contact PIFormulation Development and Clinical Manufacturing: Manufacture of TLC-ART101 Bulk Product for Clinical Trials$294.8Kaward amount
- 272201800001I-P00002-759302000005-4N01Contact PITask D06: Nonclinical Microbiological, Safety, Toxicology, and Pharmacokinetic Services$282.9Kaward amount
- 272201800001I-0-759302100001-1N01Contact PITask B19: Synthesis of LpxC Inhibitors with Improved Physicochemical Properties$257.1Kaward amount
- 272201800001I-0-759302100002-1N01Contact PITASK C12: INVESTIGATION AND OPTIMIZATION OF PRECLINICAL THERAPEUTIC FORMULATIONS AGAINST RESISTANT BACTERIA$237.6Kaward amount
- 272201800001I-P00002-759302000005-2N01Contact PITask D06: Nonclinical Microbiological, Safety, Toxicology, and Pharmacokinetic Services$127.3Kaward amount
- 272201800001I-P00002-759302000006-1N01Contact PITask C08: Manufacturing of a colon-delivery formulation platform of metronidazole for treating Clostridium difficile infection$115.1Kaward amount
+4 more grants not shown.
Award organization
Organizations that administered FY2021 awards listing Mirsalis, Jon as a PI.
FY2021 award administered by SRI International (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardSRI International
- 2007$500K Cumulative Funding
- 2007$1M Cumulative Funding
- 2007$2M Cumulative Funding
- 2007$5M Cumulative Funding
- 2007$10M Cumulative Funding
- 2007Entered Top 50% NationallyRanked #124
- 2007Entered Top 25% NationallyRanked #124
- 2007Entered Top 10% NationallyRanked #124
- 2007Entered Top 5% NationallyRanked #124
- 2007Entered Top 1% NationallyRanked #124
- 2017$25M Cumulative Funding
- 2023$50M Cumulative Funding